EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Current status and problems in the diagnosis and treatment of premenstrual syndrome and premenstrual dysphoric disorder from the perspective of obstetricians and gynecologists in Japan

Kana Yoshimi iD, Fumi Inoue, Tamami Odai, Nahoko Shirato, Zen Watanabe, Tempei Otsubo, Masakazu Terauchi iD, Takashi Takeda iD

Journal of Obstetrics and Gynaecology Research · 2023-05 · 49 (5) · 1375-1382

DOI: 10.1111/jog.15618 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Obstetrics and Gynaecology Research, online erschienen am 23.02.2023. Verfasst von Kana Yoshimi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Women's Health, Research Institute of Traditional Asian Medicine, Kindai University, Osaka-Sayama, Osaka, Japan. Hauptthemen laut MEDLINE: Premenstrual Dysphoric Disorder, Premenstrual Syndrome. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

To investigate the current status and problems in the diagnosis and treatment of premenstrual syndrome (PMS) and premenstrual dysphoric disorder (PMDD) from the perspective of obstetricians and gynecologists (OB/GYNs) in Japan, the Japanese Society of Obstetrics and Gynecology (JSOG) conducted a national‐wide survey.

Methods

An email survey was sent to all JSOG members (16 732) and a web‐based survey was conducted using a Google form between September and November 2021. The current status and problems in PMS/PMDD diagnosis and treatment were surveyed in this cross‐sectional study.

Results

In total, 1312 respondents (7.8% of all JSOG members) completed the questionnaire. In terms of diagnoses and treatment, OB/GYN was preferred over psychiatrist for PMS (91.4% vs. 45%); however, no differences were noted for PMDD (76.1% vs. 73.7%). A total of 1267 (96.6%) respondents engaged in routine PMS/PMDD treatment. Regarding the general diagnosis procedure, 84.4% respondents answered “only a vague medical interview,” 8.4% kept a two‐cycle symptom diary, and 10.3% used a screening questionnaire. The most commonly used medication was oral contraceptive pills (OCPs) (98.1%), followed by the Kampo, traditional Japanese herbal medicines, Kamishoyosan (73.6%). Concerning first‐line drugs for treatment, OCPs were the most common (76.8%), followed by Kampo medicine (19.5%); selective serotonin reuptake inhibitors (SSRIs) were less frequently used (2.6%). Regarding first‐line drugs among OCPs, 65.1% respondents reported drospirenone‐ethinylestradriol use.

Conclusions

This study indicates that only a few OB/GYNs practicing PMS/PMDD in Japan use a prospective diary, which is an essential diagnostic criterion for PMS/PMDD. Regarding treatment, SSRIs were used less frequently.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Premenstrual Dysphoric DisorderPremenstrual SyndromeFemaleHumansGynecologistsObstetriciansSelective Serotonin Reuptake InhibitorsJapanProspective StudiesCross-Sectional StudiesContraceptives, Oral

Stichwörter der Autor:innen

diagnostic criteriaoral contraceptive pillspremenstrual dysphoric disorderpremenstrual syndromeselective serotonin reuptake inhibitors

Substanzen

Selective Serotonin Reuptake InhibitorsContraceptives, Oral

Autor:innen und Institutionen

  • Division of Women's Health, Research Institute of Traditional Asian Medicine, Kindai University, Osaka-Sayama, Osaka, Japan.
  • Department of Women's Health, Tokyo Medical and Dental University, Tokyo, Japan.
  • Department of Obstetrics and Gynecology, Showa University School of Medicine, Tokyo, Japan.
  • Department of Obstetrics and Gynecology, Tohoku University Graduate School of Medicine, Sendai, Japan.
  • Department of Psychiatry, Adachi Medical Center, Tokyo Women's Medical University, Tokyo, Japan.

ORCID-Profile: Kana Yoshimi, Masakazu Terauchi, Takashi Takeda

Zitieren

APA

Yoshimi, K., Inoue, F., Odai, T., Shirato, N., Watanabe, Z., Otsubo, T., Terauchi, M., & Takeda, T. (2023). Current status and problems in the diagnosis and treatment of premenstrual syndrome and premenstrual dysphoric disorder from the perspective of obstetricians and gynecologists in Japan. Journal of Obstetrics and Gynaecology Research, 49(5), 1375-1382. https://doi.org/10.1111/jog.15618

Vancouver

Yoshimi K, Inoue F, Odai T, Shirato N, Watanabe Z, Otsubo T, et al. Current status and problems in the diagnosis and treatment of premenstrual syndrome and premenstrual dysphoric disorder from the perspective of obstetricians and gynecologists in Japan. Journal of Obstetrics and Gynaecology Research. 2023;49(5):1375-1382. doi:10.1111/jog.15618

BibTeX
@article{Yoshimi2023,
  author = {Yoshimi, Kana and Inoue, Fumi and Odai, Tamami and Shirato, Nahoko and Watanabe, Zen and Otsubo, Tempei and Terauchi, Masakazu and Takeda, Takashi},
  title = {Current status and problems in the diagnosis and treatment of premenstrual syndrome and premenstrual dysphoric disorder from the perspective of obstetricians and gynecologists in Japan},
  journal = {Journal of Obstetrics and Gynaecology Research},
  year = {2023},
  volume = {49},
  number = {5},
  pages = {1375--1382},
  doi = {10.1111/jog.15618}
}
Kostenlos starten →